ABCL-088 Subgroup Analysis in RE-MIND2: An Observational, Retrospective Cohort Study of Tafasitamab + Lenalidomide Versus Systemic Therapies in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma
Grzegorz Nowakowski, Dok Hyun Yoon, Erel Joffe, Pier Luigi Zinzani, Lorenzo Sabatelli, Eva E. Waltl, Carmelita G. Alvero, Georg Hess, Peter Riedell, Kibum Kim, Diana Brixner, Gilles Salles
Research output: Contribution to journal › Article › peer-review
Fingerprint
Dive into the research topics of 'ABCL-088 Subgroup Analysis in RE-MIND2: An Observational, Retrospective Cohort Study of Tafasitamab + Lenalidomide Versus Systemic Therapies in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma'. Together they form a unique fingerprint.